HomeIndustry & Data Room
Manage controlled industry engagement, partner diligence, disclosure boundaries, and qualified-asset data rooms.
Confidentiality is reviewed separately from scientific engagement
3 engagements
| Engagement | Partner | Asset | Stage | Confidentiality | Data Room | TTO Owner | Last Activity | Next Action |
|---|---|---|---|---|---|---|---|---|
| ENG-001 | Pharma Partner A | OGC-2401 | Diligence | NDA Executed | DR-001 | Ms. N. Adams | 2026-10-03 | Review diligence questions |
| ENG-002 | Biotech Partner B | OGC-NS-321 | Scientific Discussion | NDA Under Review | — | Mr. T. Jacobs | 2026-10-02 | Complete NDA review |
| ENG-003 | Research Partner C | OGC-LU-104 | Sponsored Validation | Confidential | DR-003 | Ms. N. Adams | 2026-09-30 | Prepare approved evidence package |